Literature DB >> 11245048

Experimental study on distribution of serotypes and antimicrobial patterns of group B streptococcus strains.

A Shen1, Y Zhu, G Zhang, Y Yang, Z Jiang.   

Abstract

OBJECTIVE: To obtain information on the distribution of serotypes and antimicrobial agent susceptibilities to group B streptococcus (GBS) strains isolated in Beijing area from 1991 to 1996.
METHODS: Bacterial isolates of GBS were obtained from vaginal and cervical tract of pregnant and nonpregnant women in Beijing Tian Tan Hospital by culture. A total of 76 GBS strains were identified finally by coagglutination. Serotyping was determined by Standard Lancefield method. Susceptibility to test agents was assessed by determining the minimal inhibitory concentrations (MICs) with agar dilution method that was established by the National Committee for Clinical Laboratory Standards (NCCLS).
RESULTS: Seven serotypes were identified among 76 GBS strains isolates. Types II (33%), III (23%) and I a (16%) were the predominant serotypes in pregnant and nonpregnant women. MICs of penicillin G and ampicillin were < or = 0.06 microgram/ml. MICs of cephazolin, cefuroxime and cefoperozone were 0.003 microgram/ml-0.06 microgram/ml. MICs of erythromycin were 0.003 microgram/ml-0.03 microgram/ml. MICs of gentamycin were 1 microgram/ml-32 micrograms/ml. MICs of amikacin were 4 micrograms/ml- > or = 64 micrograms/ml, nearly 12.8% and 40.4% of the strains were resistant to gentamycin and amikacin, respectively.
CONCLUSIONS: Our study provides useful epidemiologic data for preparation of GBS type-specific vaccines which can prevent GBS infections and antimicrobial agents susceptibility patterns in China. Routine reports on GBS susceptibilities by clinical laboratories and continuous surveillance for changes in the susceptibility are of considerable clinical importance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11245048

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Use of a serotype-specific DNA microarray for identification of group B Streptococcus (Streptococcus agalactiae).

Authors:  Linyan Wen; Quan Wang; Yayue Li; Fanrong Kong; Gwendolyn L Gilbert; Boyang Cao; Lei Wang; Lu Feng
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci).

Authors:  Baharak Afshar; Karen Broughton; Roberta Creti; Antoaneta Decheva; Markus Hufnagel; Paula Kriz; Lotte Lambertsen; Marguerite Lovgren; Pierrette Melin; Graziella Orefici; Claire Poyart; Andreas Radtke; Javier Rodriguez-Granger; Uffe B Skov Sørensen; John Telford; Lea Valinsky; Levantia Zachariadou; Androulla Efstratiou
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

3.  Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China.

Authors:  Ping Wang; Jing-jing Tong; Xiu-hua Ma; Feng-li Song; Ling Fan; Cui-mei Guo; Wei Shi; Sang-jie Yu; Kai-hu Yao; Yong-hong Yang
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.